Landscapes / Targets
adenosine A2a receptor
5 drugs act on adenosine A2a receptor, in 5 active trials · Any stage · updated 19 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs5
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Regadenosonnot checked |
Adenosine receptor agonist |
GE Healthcare +1 |
Approved | Dec 2026Phase 1/2 trial completes | |
| Next date | Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Myocardial Ischemia, Coronary Artery Disease | ||||
| Open drug page | |||||
— |
Phase 2/3 | 1 Oct 2027Phase 2/3 trial completes | |||
| Next date | 1 Oct 2027 · Phase 2/3 trial completes | ||||
| Also tested for | Parkinson Disease (PD) | ||||
| Open drug page | |||||
— |
Phase 1/2 | 1 Dec 2028Phase 1/2 trial completes | |||
| Next date | 1 Dec 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Renal Cell Cancer, Castrate Resistant Prostate Cancer and 2 more | ||||
| Open drug page | |||||
— |
Phase 2 | — | |||
| Also tested for | Metastatic NSCLC - Non-Small Cell Lung Cancer, Locally Advanced NSCLC - Non-Small Cell Lung Cancer | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 4 of 5 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · openFDA updated 19 Nov 2026